In a significant development for colorectal cancer treatment, Takeda has successfully obtained FDA approval for Fruzaqla, a VEGF inhibitor, as…
Browsing: Curated GI articles
Two innovative treatment regimens have shown promising results in patients with gastroesophageal cancers, as presented in a recent ASCO Plenary…
The World Health Organization (WHO) has recently published a set of important regulatory considerations for the use of artificial intelligence…
A recent peer-reviewed study published in Nature Communications introduces MSIntuit™ CRC, an innovative AI-driven digital pathology diagnostic tool developed by…
Mainz Biomed, a German cancer diagnostic firm, has partnered with Liquid Biosciences to use their artificial intelligence platform, Emerge, for…
Many physicians are seriously considering their practical options for a career that has nothing to do with clinical work. Perhaps…
The recent updates finalized by the Centers for Medicare & Medicaid Services (CMS) to its physician fee schedule for 2024…
Insights from Dr. James Leavitt, the director of clinical innovation for Gastro Health. He discusses the evolving landscape of private…
This U.S.-based spinoff, named Intelligent Scopes Corp., is focused on developing and delivering endoscopic image processing and AI-assisted diagnostic solutions…
This collaboration aims to revolutionize precision medicine and artificial intelligence (AI)-enabled digital pathology solutions for metabolic dysfunction-associated steatohepatitis (MASH), previously…